CRISPR Cas9–Licensing What Can't Be Licensed

les Nouvelles - Journal of the Licensing Executives Society, Volume LIII No. 2, June 2018

9 Pages Posted: 18 Jun 2018

Date Written: April 17, 2018

Abstract

A new gene engineering technology has recently made it through the media, not only because of its technical advantages, but also because it is in the focus of an epic patent battle between two academic institutions.

The technology bears the cryptic name “CRISPR Cas9,” and allows the manipulation of genes (so called “gene editing”) with so far unseen simplicity and efficacy. Dana Carroll of the University of Utah said for this reason that CRISPR Cas9 has brought about the “democratization of gene targeting.”

Keywords: CRISPR Cas9, engineering technology, Dana Carroll university of Utah

Suggested Citation

Storz, Ulrich, CRISPR Cas9–Licensing What Can't Be Licensed (April 17, 2018). les Nouvelles - Journal of the Licensing Executives Society, Volume LIII No. 2, June 2018, Available at SSRN: https://ssrn.com/abstract=3164392

Here is the Coronavirus
related research on SSRN

Paper statistics

Downloads
65
Abstract Views
301
rank
376,987
PlumX Metrics